Fact CheckerSign in

NCT07373756Not yet recruitingPhase 4

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

Effectiveness Of Aspirin In The Prevention Of Preeclampsia In High Gestosis Scored Women Attending Tertiary Level Hospital In Kathmandu: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

Preeclampsia in pregnancy is a dreaded complication which has both fetal and maternal adverse outcomes. Studies and WHO have advocated that this complication can be prevented by Aspirin. However which dose is more effective in preventing preeclampsia, whether 75mg or 150mg, will be known from this study.

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
86 (estimated)
First submitted
14 Jan 2026
Start date
15 Jan 2026
Primary completion date
31 Dec 2026
Lead sponsor
Dr. Sunita Pun
NCT number
NCT07373756

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 86
  • From 15 Jan 2026 to the primary completion date, 31 Dec 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • • Known hypersensitivity to aspirin, uncontrolled asthma with NSAID sensitivity
    • Bleeding disorders, platelet dysfunction, thrombocytopenia, anticoagulant use, active peptic ulcer, history of GI bleed, severe hepatic/ renal disease

Who the study is looking for

  • • All pregnant women with Gestosis score of 3 or more who consents for the study and aged 18 years and above.

Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.